20-F: Draganfly Inc. Issues Warrants to Armistice Capital Master Fund Ltd.

Draganfly Inc. grants Armistice Capital Master Fund Ltd. warrants to purchase common shares, outlining terms, exercise conditions, and adjustment possibilities.

Summary

• Draganfly Inc. has issued common share purchase warrants to Armistice Capital Master Fund Ltd., allowing the holder to purchase up to 16,666,666 common shares before August 21, 2029, at an exercise price of CAD$0.2048 per share.
• The warrants are subject to exercise limitations to prevent the holder from owning more than 4.99% (or 9.99% with prior election) of the outstanding common shares after exercise.
• The exercise price and number of warrant shares are subject to adjustments for share dividends, splits, rights offerings, and special distributions.
• In the event of a fundamental transaction, the holder has the right to receive shares or consideration of the successor entity.
• The warrant agreement is governed by the laws of the State of New York, and legal proceedings will be commenced exclusively in the state and federal courts sitting in the City of New York.
• The company has also issued pre-funded common share purchase warrants to Armistice Capital Master Fund Ltd., allowing the holder to purchase up to 8,000,000 common shares at a nominal exercise price of CA$0.00014 per Warrant Share.
• The company has also issued common share purchase warrants to Armistice Capital Master Fund Ltd., allowing the holder to purchase up to 1,600,000 common shares at an exercise price of CAD$3.3086 per share.

Sentiment

Score: 6

Explanation: The document is neutral in tone, outlining the terms of a financial agreement. It doesn't express positive or negative sentiment, but rather presents the facts of the warrant issuance.

Positives

• The warrants provide Draganfly with potential future capital if exercised.
• The pre-funded warrants provide Draganfly with immediate capital.
• The agreements outline clear terms and conditions for the warrants, reducing potential disputes.

Negatives

• The exercise of warrants could dilute existing shareholders' equity.
• The company may be obligated to issue a significant number of shares if the warrants are exercised.
• The company may be required to pay cash compensation if it fails to deliver warrant shares on time.

Risks

• The holder's exercise of warrants is subject to beneficial ownership limitations, which could affect the timing and amount of potential capital inflow.
• Adjustments to the exercise price and warrant shares could negatively impact the company's capital structure.
• The company may face legal and financial risks associated with potential disputes and litigation related to the warrant agreement.
• The company may be required to pay cash compensation if it fails to deliver warrant shares on time.

Future Outlook

The document outlines the terms for potential future equity issuances through the exercise of warrants, which could provide the company with additional capital.

Industry Context

This announcement is typical for companies seeking to raise capital and provides insights into the terms and conditions of the agreement with a specific institutional investor.

Comparison to Industry Standards

• The warrant terms, including exercise price, expiration date, and adjustment clauses, are generally consistent with industry standards for similar financing agreements.
• The beneficial ownership limitation is a common provision to protect the company from potential hostile takeovers or undue influence by a single shareholder.
• The liquidated damages clause for failure to deliver warrant shares on time is a standard protection for the investor.

Stakeholder Impact

• Existing shareholders may experience dilution if the warrants are exercised.
• The company may benefit from the additional capital raised through warrant exercises.
• Armistice Capital Master Fund Ltd. will have the opportunity to increase its stake in Draganfly Inc.

Next Steps

• Armistice Capital Master Fund Ltd. may choose to exercise the warrants to purchase common shares.
• Draganfly Inc. must reserve a sufficient number of common shares for potential warrant exercises.
• The company must monitor and comply with the terms of the warrant agreements, including potential adjustments to the exercise price and warrant shares.

Key Dates

Keywords

warrants, common shares, exercise price, Armistice Capital, Draganfly, pre-funded warrants, beneficial ownership, British Columbia